tiprankstipranks
Trending News
More News >
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ:RNAC

Compare Cartesian Therapeutics (RNAC) vs. Competitors

Compare
1,149 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Cartesian Therapeutics
$6.51
$174.96M
-1.44
-58.88%
5 Buy
1 Hold
0 Sell
Strong Buy
Puma Biotechnology
$6.12
$317.98M
9.56
78.06%
0 Buy
1 Hold
0 Sell
Hold
DBV Technologies SA - American
$20.19
$1.09B
-1.46
304.61%
2 Buy
0 Hold
0 Sell
Moderate Buy
Voyager Therapeutics
$3.88
$231.25M
-1.93
0.00%
8 Buy
0 Hold
0 Sell
Strong Buy
Atea Pharmaceuticals
$5.66
$443.77M
-1.84
72.98%
2 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$12.04
$526.89M
-0.10
-27.07%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RNAC
Cartesian Therapeutics
6.60
-9.34
-58.59%
PBYI
Puma Biotechnology
6.25
2.78
80.12%
DBVT
DBV Technologies SA - American
20.19
15.73
352.69%
VYGR
Voyager Therapeutics
3.88
-0.03
-0.77%
AVIR
Atea Pharmaceuticals
5.57
2.37
74.06%
VOR
Vor Biopharma
12.69
-5.00
-28.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts